We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.43%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$46.1B
AUM Growth
+$6.94B
(+18%)
Cap. Flow
+$2.24B
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
24.2%
Holding
995
New
107
Increased
596
Reduced
238
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$231M |
| 2 |
Amgen
AMGN
|
+$171M |
| 3 |
Johnson & Johnson
JNJ
|
+$158M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$153M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$209M |
| 2 |
Broadcom
AVGO
|
+$207M |
| 3 |
TJX Companies
TJX
|
+$195M |
| 4 |
Emerson Electric
EMR
|
+$193M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.07% |
| 2 | Healthcare | 17.55% |
| 3 | Financials | 10.75% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Masco
MAS
$16B
| $6.5M | 0.01% |
97,052
+37,639
| +63% | +$2.19M |
|
627
Zoom
ZM
$25.8B
| $6.48M | 0.01% |
90,119
+45,912
| +104% | +$3.04M |
|
628
Celanese
CE
$5.09B
| $6.47M | 0.01% |
41,643
+17,081
| +70% | +$2.23M |
|
629
Markel Group
MKL
$25B
| $6.4M | 0.01% |
4,508
+2,226
| +98% | +$3.16M |
|
630
Nu Holdings
NU
$68.1B
| $6.37M | 0.01% |
767,497
+403,656
| +111% | +$3.26M |
|
631
Caesars Entertainment
CZR
$6.1B
| $6.35M | 0.01% |
135,429
+39,338
| +41% | +$1.75M |
|
|
LOMA
632
Loma Negra
LOMA
$1.33B
| $6.33M | 0.01% |
892,800
-7,000
| -0.8% | -$44.6K |
|
633
Tyson Foods
TSN
$20.2B
| $6.3M | 0.01% |
117,217
+48,029
| +69% | +$2.33M |
|
634
United Therapeutics
UTHR
$26.3B
| $6.22M | 0.01% |
+28,276
| New | +$6.52M |
|
635
Qorvo
QRVO
$7.63B
| $6.2M | 0.01% |
55,064
+18,326
| +50% | +$1.77M |
|
636
Coupang
CPNG
$27.8B
| $6.19M | 0.01% |
363,978
+197,705
| +119% | +$3.26M |
|
637
Conagra Brands
CAG
$7.07B
| $6.16M | 0.01% |
215,059
+30,915
| +17% | +$866K |
|
|
LTC
638
LTC Properties
LTC
$2.16B
| $6.1M | 0.01% |
189,978
+181,683
| +2,190% | +$5.88M |
|
639
Leidos
LDOS
$14.1B
| $6.09M | 0.01% |
56,234
+23,638
| +73% | +$2.41M |
|
640
Live Nation Entertainment
LYV
$41.2B
| $6.07M | 0.01% |
64,848
+26,877
| +71% | +$2.31M |
|
|
MRNS
641
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $6.01M | 0.01% |
+552,572
| New | +$4.14M |
|
642
iShares Biotechnology ETF
IBB
$9.31B
| $5.93M | 0.01% |
+43,634
| New | +$5.32M |
|
643
Zebra Technologies
ZBRA
$12.4B
| $5.87M | 0.01% |
21,475
+8,851
| +70% | +$2.02M |
|
644
GeoPark
GPRK
$649M
| $5.81M | 0.01% |
678,044
-16,360
| -2% | -$155K |
|
645
Revvity
RVTY
$12.3B
| $5.75M | 0.01% |
52,609
+21,643
| +70% | +$2.09M |
|
646
NiSource
NI
$22.4B
| $5.67M | 0.01% |
213,671
+115,146
| +117% | +$2.96M |
|
647
J.M. Smucker
SJM
$12.6B
| $5.66M | 0.01% |
44,808
+18,016
| +67% | +$2.09M |
|
648
MGM Resorts International
MGM
$11.7B
| $5.65M | 0.01% |
126,372
+39,438
| +45% | +$1.55M |
|
649
KeyCorp
KEY
$24.3B
| $5.63M | 0.01% |
390,946
+161,059
| +70% | +$1.91M |
|
650
Globe Life
GL
$13.5B
| $5.62M | 0.01% |
46,160
+22,755
| +97% | +$2.68M |
|
Similar funds
Aberdeen Group's Q4 2023 Portfolio in Review
As of Q4 2023, Aberdeen Group held 995 positions worth $46.1B, up 18% from $39.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aberdeen Group deployed $2.24B of net new capital in Q4 2023, opening 107 new positions and adding to 596 existing holdings. Its largest new stake was Veralto: 984,184 shares worth $81M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Microsoft, an estimated $209M trimmed.
- Aberdeen Group's largest Q4 2023 buy was Veralto: 984,184 shares worth $81M.
- Aberdeen Group added most to NVIDIA in Q4 2023, an estimated $231M increase.
- Aberdeen Group's biggest Q4 2023 reduction was Microsoft, cutting an estimated $209M.
- Aberdeen Group fully exited VMware, Inc in Q4 2023, selling an estimated $61M.
- Aberdeen Group's ten largest holdings make up 24% of its $46.1B portfolio in Q4 2023.
- Aberdeen Group opened 107 new positions and closed 35 in Q4 2023.
- Aberdeen Group's portfolio value rose 18% quarter-over-quarter to $46.1B.
Based on Aberdeen Group's 13F filing for Q4 2023, filed 31 Jan 2024.